{"title":"甲状腺功能正常人群中甲状腺激素敏感性受损与肝纤维化风险增加相关:NHANES的横断面分析","authors":"Xingyu Yao, Kaiwen Xiao, Hein Ko Oo","doi":"10.1055/a-2700-6797","DOIUrl":null,"url":null,"abstract":"<p><p>The interplay between liver fibrosis and thyroid function remains incompletely understood, particularly regarding thyroid hormone sensitivity. Thus, this study aims to explore the relationship between liver fibrosis and thyroid hormone sensitivity in euthyroid U.S. individuals. This study involved 4678 euthyroid participants from the National Health and Nutrition Examination Survey 2007-2012. Key clinical parameters were extracted, including thyroid-stimulating hormone (TSH), free and total thyroxine, and liver function related data. Thyroid hormone sensitivity was assessed by three indices: the Thyroid Feedback Quantile-based Index (TFQI), TSH index (TSHI), and thyrotrophic thyroxine resistance index (TT4RI). Multiple regression analyses and machine learning models were performed to evaluate the relationships between liver fibrosis and thyroid sensitivity indices. Participants with advanced liver fibrosis indicated by fibrosis index 4 (FIB-4) demonstrated significantly impaired thyroid hormone sensitivity indicated by TFQI, TT4RI, and TSHI. Then the logistic regression and restricted cubic spline analysis indicated that TFQI, TT4RI, and TSHI were risk factors for liver fibrosis (OR>1, p < 0.05). Furthermore, we developed machine learning models using random forest and Boruta's algorithm identifying thyroid hormone sensitivity indices, TSHI, TT4RI, and TFQI as key predictors for liver fibrosis. Mediation analysis indicates that uric acid is a weak mediator between thyroid hormone sensitivity and liver fibrosis. This study reveals that impaired thyroid hormone sensitivity is a risk factor is a risk factor for liver fibrosis progression in euthyroid individuals. These findings uncover a potential molecular link between thyroid hormone signaling and the development of liver fibrosis, warranting further investigation.</p>","PeriodicalId":12999,"journal":{"name":"Hormone and Metabolic Research","volume":" ","pages":""},"PeriodicalIF":1.8000,"publicationDate":"2025-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Impaired Thyroid Hormone Sensitivity is Associated with Increased Risk of Liver Fibrosis in Euthyroid Population: A Cross-Sectional Analysis of NHANES.\",\"authors\":\"Xingyu Yao, Kaiwen Xiao, Hein Ko Oo\",\"doi\":\"10.1055/a-2700-6797\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>The interplay between liver fibrosis and thyroid function remains incompletely understood, particularly regarding thyroid hormone sensitivity. Thus, this study aims to explore the relationship between liver fibrosis and thyroid hormone sensitivity in euthyroid U.S. individuals. This study involved 4678 euthyroid participants from the National Health and Nutrition Examination Survey 2007-2012. Key clinical parameters were extracted, including thyroid-stimulating hormone (TSH), free and total thyroxine, and liver function related data. Thyroid hormone sensitivity was assessed by three indices: the Thyroid Feedback Quantile-based Index (TFQI), TSH index (TSHI), and thyrotrophic thyroxine resistance index (TT4RI). Multiple regression analyses and machine learning models were performed to evaluate the relationships between liver fibrosis and thyroid sensitivity indices. Participants with advanced liver fibrosis indicated by fibrosis index 4 (FIB-4) demonstrated significantly impaired thyroid hormone sensitivity indicated by TFQI, TT4RI, and TSHI. Then the logistic regression and restricted cubic spline analysis indicated that TFQI, TT4RI, and TSHI were risk factors for liver fibrosis (OR>1, p < 0.05). Furthermore, we developed machine learning models using random forest and Boruta's algorithm identifying thyroid hormone sensitivity indices, TSHI, TT4RI, and TFQI as key predictors for liver fibrosis. Mediation analysis indicates that uric acid is a weak mediator between thyroid hormone sensitivity and liver fibrosis. This study reveals that impaired thyroid hormone sensitivity is a risk factor is a risk factor for liver fibrosis progression in euthyroid individuals. These findings uncover a potential molecular link between thyroid hormone signaling and the development of liver fibrosis, warranting further investigation.</p>\",\"PeriodicalId\":12999,\"journal\":{\"name\":\"Hormone and Metabolic Research\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":1.8000,\"publicationDate\":\"2025-09-11\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Hormone and Metabolic Research\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1055/a-2700-6797\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"ENDOCRINOLOGY & METABOLISM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hormone and Metabolic Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1055/a-2700-6797","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0
摘要
肝纤维化和甲状腺功能之间的相互作用仍不完全清楚,特别是关于甲状腺激素敏感性。因此,本研究旨在探讨美国甲状腺功能正常个体肝纤维化与甲状腺激素敏感性之间的关系。本研究涉及2007-2012年全国健康与营养检查调查的4678名甲状腺功能正常的参与者。提取关键临床参数,包括促甲状腺激素(TSH)、游离甲状腺素和总甲状腺素以及肝功能相关数据。采用甲状腺反馈分位数指数(TFQI)、TSH指数(TSHI)和促甲状腺素抵抗指数(TT4RI) 3个指标评价甲状腺激素敏感性。采用多元回归分析和机器学习模型评估肝纤维化与甲状腺敏感性指标之间的关系。以纤维化指数4 (FIB-4)为指标的晚期肝纤维化患者表现出TFQI、TT4RI和TSHI指标的甲状腺激素敏感性显著受损。logistic回归和限制性三次样条分析显示,TFQI、TT4RI、TSHI是肝纤维化的危险因素(OR bbb1, p < 0.05)。此外,我们开发了机器学习模型,使用随机森林和Boruta算法识别甲状腺激素敏感性指数,TSHI, TT4RI和TFQI作为肝纤维化的关键预测因子。中介分析表明尿酸在甲状腺激素敏感性与肝纤维化之间是弱中介。本研究表明,甲状腺激素敏感性受损是甲状腺功能正常个体肝纤维化进展的一个危险因素。这些发现揭示了甲状腺激素信号与肝纤维化发展之间的潜在分子联系,值得进一步研究。
Impaired Thyroid Hormone Sensitivity is Associated with Increased Risk of Liver Fibrosis in Euthyroid Population: A Cross-Sectional Analysis of NHANES.
The interplay between liver fibrosis and thyroid function remains incompletely understood, particularly regarding thyroid hormone sensitivity. Thus, this study aims to explore the relationship between liver fibrosis and thyroid hormone sensitivity in euthyroid U.S. individuals. This study involved 4678 euthyroid participants from the National Health and Nutrition Examination Survey 2007-2012. Key clinical parameters were extracted, including thyroid-stimulating hormone (TSH), free and total thyroxine, and liver function related data. Thyroid hormone sensitivity was assessed by three indices: the Thyroid Feedback Quantile-based Index (TFQI), TSH index (TSHI), and thyrotrophic thyroxine resistance index (TT4RI). Multiple regression analyses and machine learning models were performed to evaluate the relationships between liver fibrosis and thyroid sensitivity indices. Participants with advanced liver fibrosis indicated by fibrosis index 4 (FIB-4) demonstrated significantly impaired thyroid hormone sensitivity indicated by TFQI, TT4RI, and TSHI. Then the logistic regression and restricted cubic spline analysis indicated that TFQI, TT4RI, and TSHI were risk factors for liver fibrosis (OR>1, p < 0.05). Furthermore, we developed machine learning models using random forest and Boruta's algorithm identifying thyroid hormone sensitivity indices, TSHI, TT4RI, and TFQI as key predictors for liver fibrosis. Mediation analysis indicates that uric acid is a weak mediator between thyroid hormone sensitivity and liver fibrosis. This study reveals that impaired thyroid hormone sensitivity is a risk factor is a risk factor for liver fibrosis progression in euthyroid individuals. These findings uncover a potential molecular link between thyroid hormone signaling and the development of liver fibrosis, warranting further investigation.
期刊介绍:
Covering the fields of endocrinology and metabolism from both, a clinical and basic science perspective, this well regarded journal publishes original articles, and short communications on cutting edge topics.
Speedy publication time is given high priority, ensuring that endocrinologists worldwide get timely, fast-breaking information as it happens.
Hormone and Metabolic Research presents reviews, original papers, and short communications, and includes a section on Innovative Methods. With a preference for experimental over observational studies, this journal disseminates new and reliable experimental data from across the field of endocrinology and metabolism to researchers, scientists and doctors world-wide.